Inspiremd announces successful first-in-human procedure utilizing cguard prime, its next generation carotid artery stent (cas) platform

Procedure performed as part of the company's ongoing cguardians u.s. investigational device exemption (ide) trial designed to support potential u.s. marketing approval of the cguard stent system

NSPR Ratings Summary

NSPR Quant Ranking